Atlas Trials

Ex Vivo Drug Response Evaluation for Next Generation Care of Brain Metastases

Clinical trial NCT06620380 · RECRUITING

Trial details

NCT number
NCT06620380
Sponsor
University of Zurich
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Brain MetastasesBrain Metastases, Adult
Start date
2025-09-12
Primary completion
2026-09-01
Enrollment
102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.